Mehmet Sofuoglu
Overview
Explore the profile of Mehmet Sofuoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
3912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ameral V, Sofuoglu M, Kelly M
Expert Rev Clin Pharmacol
. 2025 Mar;
:1-8.
PMID: 40047379
Introduction: Smoking cessation improves quality of life and increases life expectancy by up to a decade. Though two-thirds of people who smoke report a desire to quit, less than a...
2.
Wolkowicz N, Parida S, Gueorguieva R, Sofuoglu M
Pharmacol Biochem Behav
. 2025 Feb;
249:173985.
PMID: 40010441
Background: Limited research exists on how switching from menthol to non-menthol cigarettes affects the acute response to nicotine for individuals who smoke menthol cigarettes. Such research can inform public health...
3.
Costa G, Nunes J, Suh R, Sofuoglu M, Aquino J
Drug Alcohol Depend
. 2025 Jan;
268:112552.
PMID: 39848133
Background: Tobacco smoking remains the leading preventable cause of death, whereas chronic pain is the leading cause of disability. Chronic pain and tobacco smoking are closely interrelated. We investigated whether...
4.
Sofuoglu M, MacLean R, Aquino J
Br J Clin Pharmacol
. 2024 Sep;
90(12):2960-2961.
PMID: 39340184
No abstract available.
5.
DeVito E, Ameral V, Sofuoglu M
Br J Clin Pharmacol
. 2024 Aug;
90(12):3067-3083.
PMID: 39168150
Opioid use disorder (OUD) and chronic pain are commonly co-occurring disorders which can exacerbate each other. Sex/gender differences have been shown in aspects of the clinical course and biological underpinnings...
6.
Yoon G, Sofuoglu M, Petrakis I, Pittman B, Bell M
Contemp Clin Trials
. 2024 Aug;
145:107657.
PMID: 39111388
Background: The development of alcohol use disorder (AUD) is a major concern in public health, and cognitive impairments caused by alcohol are involved in this process. Emerging neurobiological evidence suggests...
7.
Wolkowicz N, Sofuoglu M, Pittman B, Meyerovich J, MacLean R, Aquino J
J Psychiatr Res
. 2024 Jul;
177:90-95.
PMID: 38991269
Introduction: Attentional bias (AB) is believed to be an important factor in the development and maintenance of both opioid use disorder (OUD) and chronic pain. Cannabis and its main psychoactive...
8.
Parida S, MacLean R, Gueorguieva R, Sofuoglu M
Psychopharmacology (Berl)
. 2024 Jul;
241(9):1915-1922.
PMID: 38970644
Rationale: No previous studies examined the discriminative stimulus effects of intravenous (IV) nicotine in humans. Objectives: To evaluate a pulsed IV nicotine infusion procedure designed to mimic inhaled nicotine delivery...
9.
Schwartz E, Palmisano A, Petrakis I, Pietrzak R, Sofuoglu M
J Psychiatr Res
. 2024 Jun;
176:213-217.
PMID: 38878649
Introduction: Avoidance is a well-documented risk factor for poor mental and physical health outcomes. However, limited research has explored this relationship specifically among trauma-exposed veterans, a population known to be...
10.
Schwartz E, Aquino J, Sofuoglu M
Br J Clin Pharmacol
. 2024 May;
90(12):3054-3066.
PMID: 38752593
Chronic pain and opioid use disorder (OUD) are major public health problems, with rising opioid-related overdose deaths linked to increased opioid prescriptions for pain management. Novel treatment approaches for these...